TickerFacts.

Panacea Life Sciences Holdings, Inc. (PLSH): Cost of Revenue

Annual figures by period end, from SEC filings.

Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

$1.26M
Year ended 2023-12-31
-43.5%
3-year compound annual growth
$7.02M2018-12-31: $02019-12-31: $1.94M2020-12-31: $7.02M2021-12-31: $1.52M2022-12-31: $1.23M2023-12-31: $1.26M$1.26M
2018-12-31 Cost of Revenue (USD) 2023-12-31
Period endedCost of RevenueChange YoYSource filing
2023-12-31$1.26M+2.6%2024-04-01, From 2023-01-01
2022-12-31$1.23M-19.0%2024-04-01, From 2022-01-01
2021-12-31$1.52M-78.4%2023-03-30, From 2021-01-01
2020-12-31$7.02M+262.0%2022-03-31, From 2020-01-01
2019-12-31$1.94Mn/a2021-04-23, From 2019-01-01
2018-12-31$0n/a2020-05-22, From 2018-01-01